Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIlika Plc Regulatory News (IKA)

Share Price Information for Ilika Plc (IKA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 27.00
Bid: 26.00
Ask: 28.00
Change: 0.00 (0.00%)
Spread: 2.00 (7.692%)
Open: 27.50
High: 0.00
Low: 0.00
Prev. Close: 27.00
IKA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options

1 Oct 2015 15:38

RNS Number : 9796A
Ilika plc
01 October 2015
 

 

Ilika plc

("Ilika" or the "Company")

 

Grant of Options, Conversion of Preference Shares & Total Voting Rights

 

Ilika (AIM: IKA), the accelerated materials innovation company, announces that, following the passing of resolutions 6 and 7 at yesterday's Annual General Meeting ("AGM"), Ilika yesterday granted options over 160,000 ordinary shares of 1p each in the Company ("Options") to non-executive directors at an exercise price of 68.75 pence per share, being the closing mid-market price on 29 September 2015. Nominal value options over 1,674,908 ordinary shares of 1p each in the Company have been granted to executive directors.

 

The Options represent in aggregate 2.79 per cent of the existing issued share capital.

 

In addition, the Company announces that 50,000 Convertible Preference Shares have today been converted into Ordinary Shares of 1p each in the Company ("Ordinary Shares") on the basis of 1 new Ordinary Share for every 1 Convertible Preference Share. The Company has today applied for admission to trading on AIM ("Admission") of those 50,000 new Ordinary Shares. Admission is expected to occur on 7 October 2015.

 

The new Ordinary Shares rank pari passu with the Company's existing issued Ordinary Shares. Following this conversion the figure of 65,786,416 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

 

Details of the Options

 

The following unapproved share options were issued to Directors with each award vesting on the achievement of certain performance targets over a three-year period (details of which were provided in the Notice of AGM):

 

Director

Number of options granted

Total number of Options now held

Per cent. of current issued share capital

Mike Inglis

120,000

120,000

0.182%

Keith Jackson

40,000

40,000

0.061%

 

The following options were issued under the Company's recently approved Long Term Incentive Plan 2015 with each award vesting on the achievement of certain performance targets over a three-year period (details of which were provided in the Notice of AGM, Appendix 1):

 

Director

Number of options granted

Total number of Options now held

Per cent. of current issued share capital

Graeme Purdy

872,727

2,330,727

3.543%

Brian Hayden

527,272

1,289,472

1.960%

Steve Boydell

274,909

637,109

0.968%

 

Graeme Purdy holds 589,427 Ordinary shares representing 0.896% of current issued share capital and Steve Boydell holds 9,090 Ordinary shares representing 0.014% of current issued share capital. Brian Hayden holds 426,300 Preference Shares.

 

The Notice of AGM can be found here: http://www.ilika.com/images/uploads/general/AGM_notice_final.pdf

 

 

For more information contact:

 

Ilika plc

www.ilika.com

Graeme Purdy, Chief Executive

Tel: 023 8011 1400

Steve Boydell, Finance Director

 

 

 

Numis Securities Limited

Tel: 020 7260 1000

Oliver Cardigan / James Black / Paul Gillam

 

 

 

Walbrook PR Ltd

Tel: 020 7933 8780 / ilika@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07584 391 303

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCZFLFBEBFXFBD
Date   Source Headline
26th Aug 20207:00 amRNSStereax® manufacturing plans update
26th Aug 20207:00 amRNSAnnual Report & Notice of AGM
14th Aug 20203:56 pmRNSHolding(s) in Company
14th Aug 20202:06 pmRNSSecond Price Monitoring Extn
14th Aug 20202:01 pmRNSPrice Monitoring Extension
24th Jul 20202:06 pmRNSSecond Price Monitoring Extn
24th Jul 20202:01 pmRNSPrice Monitoring Extension
17th Jul 20202:06 pmRNSSecond Price Monitoring Extn
17th Jul 20202:00 pmRNSPrice Monitoring Extension
17th Jul 202011:06 amRNSSecond Price Monitoring Extn
17th Jul 202011:02 amRNSPrice Monitoring Extension
15th Jul 20204:42 pmRNSSecond Price Monitoring Extn
15th Jul 20204:37 pmRNSPrice Monitoring Extension
9th Jul 20207:00 amRNSFinal Results
16th Jun 20207:00 amRNSCOVID-19 Update, Facility Re-opening
10th Jun 20204:14 pmRNSHolding(s) in Company
10th Jun 202011:05 amRNSSecond Price Monitoring Extn
10th Jun 202011:00 amRNSPrice Monitoring Extension
9th Jun 20207:00 amRNSTrading Update & Notice of Results
8th Jun 20204:42 pmRNSSecond Price Monitoring Extn
8th Jun 20204:36 pmRNSPrice Monitoring Extension
20th Apr 20207:00 amRNSAppointment of Non-Executive Director
20th Apr 20207:00 amRNSCEO appointed as NED of Bacanora Lithium plc
6th Apr 20207:00 amRNSInvestor presentation
30th Mar 20204:25 pmRNSHolding(s) in Company
30th Mar 20202:40 pmRNSHolding(s) in Company
27th Mar 20205:26 pmRNSHolding(s) in Company
27th Mar 202010:58 amRNSHolding(s) in Company
27th Mar 20209:00 amRNSAward of Share Options, Exercise of Options & TVR
25th Mar 20201:45 pmRNSResults of General Meeting and Open Offer & TVR
25th Mar 202011:06 amRNSSecond Price Monitoring Extn
25th Mar 202011:01 amRNSPrice Monitoring Extension
25th Mar 20207:00 amRNSCOVID-19 Update
19th Mar 20204:15 pmRNSGeneral Meeting: Change of Venue
18th Mar 202011:07 amRNSSecond Price Monitoring Extn
18th Mar 202011:01 amRNSPrice Monitoring Extension
6th Mar 20205:20 pmRNSResult of Placing
6th Mar 20201:20 pmRNSProposed Placing & Open Offer
7th Feb 20207:00 amRNSGrowth & Innovation Forum 2020
4th Feb 20207:00 amRNSSuccessful Stereax Field Trial
23rd Jan 20207:00 amRNSHalf-year Report
15th Jan 202011:06 amRNSSecond Price Monitoring Extn
15th Jan 202011:01 amRNSPrice Monitoring Extension
14th Jan 20204:41 pmRNSSecond Price Monitoring Extn
14th Jan 20204:36 pmRNSPrice Monitoring Extension
13th Jan 202011:08 amRNSSecond Price Monitoring Extn
13th Jan 202011:05 amRNSPrice Monitoring Extension
10th Jan 20202:07 pmRNSSecond Price Monitoring Extn
10th Jan 20202:01 pmRNSPrice Monitoring Extension
2nd Jan 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.